|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 49.50 USD | -0.80% |
|
-0.76% | +66.05% |
| 08-03 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.08B | |||||
| 1,083B | |||||
| 626B | - | - | - | ||
| 442B | |||||
| 363B | |||||
| 295B |
- Stock Market
- Stocks
- TGTX Stock
- Charts TG Therapeutics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
